Piperidine derivatives as modulators of chemokine receptor CCR5

Details Piperidine derivatives as modulators of chemokine receptor CCR5 Piperidine derivatives as modulators of chemokine receptor CCR5

2005-04-20

2009-11-10

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S253090, C514S303000, C514S316000, C514S383000, C514S394000, C544S360000, C544S364000, C546S113000, C546S187000, C548S262200, C548S305100

Reexamination Certificate

active

07615555

ABSTRACT:
Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).

REFERENCES:
patent: 6288084 (2001-09-01), Luly et al.
patent: 7192973 (2007-03-01), Tucker
patent: 2007/0161646 (2007-07-01), Tucker
patent: 2007/0259914 (2007-11-01), Tucker
patent: 2008/0021038 (2008-01-01), Tucker et al.
patent: 2008/0139612 (2008-06-01), Faull et al.
patent: 2008/0139613 (2008-06-01), Brown et al.
patent: 0 903 349 (1999-03-01), None
patent: 1 013 276 (2000-06-01), None
patent: WO 92/02502 (1992-02-01), None
patent: WO 99/04794 (1999-02-01), None
patent: WO 99/25686 (1999-05-01), None
patent: WO 99/38514 (1999-08-01), None
patent: WO 01/14333 (2001-03-01), None
patent: WO 01/87839 (2001-11-01), None
patent: WO 01/90106 (2001-11-01), None
patent: WO 03/042205 (2003-05-01), None
patent: WO 2004/054974 (2004-07-01), None
patent: WO 2004/056773 (2004-07-01), None
patent: WO 2004/056808 (2004-07-01), None
patent: WO 2004/056809 (2004-07-01), None
patent: WO 2006/001751 (2006-01-01), None
patent: WO 2006/001752 (2006-01-01), None
Wang et al. Rheumatology,vol. 43, p. 569-573 (2004).
Cook, Reviews in Neurological Diseases, vol. 1, p. 37-40 (2004).
Owen, Pulmonary Pharmacology & Therapeutics vol. 14, p. 193-202 (2001).
Fischereder et al. The Lancet vol. 357, p. 1758-1761 (2001).
Vincenti, American Journal of Transplantation vol. 2, p. 898-903 (2002) (Abstract).

Affiliated with

Also associated with

Rating

Piperidine derivatives as modulators of chemokine receptor CCR5 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine derivatives as modulators of chemokine receptor CCR5, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives as modulators of chemokine receptor CCR5 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4075996